United States · FDA National Drug Code directory
Amlodipine besylate and Olmesartan medoxomil
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 27241-084_1c06acbb-7027-4b05-90a0-4f40c039c705
- Product NDC
- 27241-084
- Form
- TABLET
- Composition / generic term
- Amlodipine besylate and Olmesartan medoxomil
- Labeler
- Ajanta Pharma USA Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20170206
- Source listing expiry
- 20271231
Source-listed ingredients
- AMLODIPINE BESYLATE — 5 mg/1
- OLMESARTAN MEDOXOMIL — 40 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE (27241-084-03) · 27241-084-03
- 90 TABLET in 1 BOTTLE (27241-084-09) · 27241-084-09
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →